<DOC>
	<DOCNO>NCT01437813</DOCNO>
	<brief_summary>Objective : The purpose study evaluate effect food intake bioavailability ( BA ) combination Glimepiride/ extend release Metformin GLI/METXR ( 4/850mg ) healthy Mexican volunteer . Methods : A prospective , longitudinal , open label , non randomize study , perform . A single oral dose GLI/METXR ( 4/850 mg ) administer 24 health Mexican volunteer 30 min high fat meal . Blood sample collect administration 0.33 , 0.67 , 1 , 1.5 , 2 , 2.5 , 3 , 3.5 , 4 , 4.5 , 5 , 5.5 , 6.7 , 8 , 10 , 12 , 16 , 20 , 24 30 hour post-administration . Plasma concentration drug measure use HPLC . Plasma concentration botk drug measure use high-performance liquid chromatography ( HPLC ) . Plasma concentration time curve plot volunteer , pharmacokinetic parameter ( PK ) calculate . Adverse event determine use clinical laboratory test result throughout study .</brief_summary>
	<brief_title>BIOAVAILABILITY OF Glimepiride/Extended Release Metformin ( GLI/METXR ) : High Fat Diet Study</brief_title>
	<detailed_description />
	<mesh_term>Glimepiride</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Healthy Mexican volunteer , consider healthy accord standard screening assessment Aged 18 50 year old Body mass index ( BMI ) 18 27.5 Those history evidence cardiovascular , renal , hepatic , gastrointestinal , neurologic , muscular , metabolic , hematologic abnormality Any acute chronic disease Any drug allergy female volunteer positive urinary pregnancy test breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>DM2</keyword>
	<keyword>glimepiride</keyword>
	<keyword>metformin extend release</keyword>
</DOC>